Procter & Gamble maintained its topline guidance and raised the low end of its EPS guidance, but there’s limited upside to that outlook, Truist Securities analysts say in a research note. The consumer products giant continues to deal with a slower than expected recovery in China, and is seeing volume declines for its beauty, health care and baby and family care categories, analysts say. “We recommend investors stay on the sidelines at least until volume trends improve,” analysts say. Shares rise 4.3% to $154.17.